
Loading, please wait...

Loading, please wait...

Recent breakthroughs in Glabridin synthesis have paved the way for advanced dermatological and pharmaceutical applications. Glabridin is a major isoflavane found in licorice (Glycyrrhiza glabra). It is highly valued for its potent antioxidant, anti-inflammatory, and skin-whitening properties. However, extracting pure Glabridin from natural sources remains difficult and costly due to its low concentration in roots.
Researchers recently described a modular, stereodivergent chemoenzymatic strategy to produce both enantiomers of this compound. This Glabridin synthesis approach utilizes a lipase-catalyzed dynamic kinetic resolution. This specific step establishes the critical benzylic stereocenter while preserving stereochemical integrity. Consequently, the team successfully delivered (-)-glabridin in 10 steps with a 14% overall yield. Additionally, they produced (+)-glabridin in 12 steps with a 7% yield. Notably, using inexpensive, resorcinol-derived building blocks makes this platform commercially viable.
In India, licorice—known as Yashtimadhu—is a cornerstone of AYUSH practices. Traditionally, practitioners use it to treat hyperpigmentation and inflammatory skin conditions. This synthetic breakthrough provides a reliable supply of high-purity Glabridin. Furthermore, it allows researchers to investigate the distinct biological activities of each enantiomer. Most current dermatological formulations rely on racemic mixtures or crude extracts. However, the ability to synthesize specific enantiomers could lead to more targeted and effective treatments for melasma and photo-aging.
Glabridin inhibits tyrosinase activity, which is the primary enzyme responsible for melanin production. This process effectively reduces hyperpigmentation and evens out skin tone without the irritation often caused by chemical lighteners.
Chemoenzymatic methods combine the precision of biological catalysts with the flexibility of organic chemistry. This allows for higher stereoselectivity and more sustainable production of complex natural molecules.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or substitute for professional judgment. Always consult with a qualified healthcare provider for specific medical concerns. Refer to the latest local and national guidelines for clinical practice.
References
Wang X et al. Modular Stereodivergent Chemoenzymatic Total Synthesis of (+)- and (-)-Glabridin. Chemistry. 2026 Mar 26. doi: 10.1002/chem.70931. PMID: 41888064.
Yokota T et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11(6):355-361.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have developed a modular chemoenzymatic strategy to synthesize both enantiomers of Glabridin, a key natural product used in dermatology and AYUS...
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today